Dr. Agravat Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 17 Year, 18 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.40 M
- Revenue Growth 191.25%
- Profit Growth 59.97%
- Ebitda 179.76%
- Net Worth 10.79%
- Total Assets 32.47%
About Dr. Agravat Healthcare
Dr. Agravat Healthcare Limited (DAHL) is a Public Limited Indian Non-Government Company incorporated in India on 24 January 2008 and has a history of 17 years. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.40 M.
Kartavya Agravat, Harshaben Agravat, and Bharat Agravat serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
-
Apps
Corporate Identity Details
-
CIN/LLPIN
U85110GJ2008PLC052729
-
Company No.
052729
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
24 Jan 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Dr. Agravat Healthcare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kartavya Agravat
|
Director | 06-Jun-2022 | Current |
|
Harshaben Agravat
|
Director | 24-Jan-2008 | Current |
|
Bharat Agravat
|
Director | 24-Jan-2008 | Current |
Financial Performance of Dr. Agravat Healthcare.
Dr. Agravat Healthcare Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 191.25% increase. The company also saw a substantial improvement in profitability, with a 59.97% increase in profit. The company's net worth Soared by an impressive increase of 10.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Agravat Healthcare?
In 2019, Dr. Agravat Healthcare had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Smile In Hour LlpHarshaben Agravat and Bharat Agravat are mutual person
Charges (Loans)
₹1.40 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Oct 2012 | Others | ₹1.40 M | Open |
How Many Employees Work at Dr. Agravat Healthcare?
Unlock and access historical data on people associated with Dr. Agravat Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Agravat Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Agravat Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
